Kapicioglu Yelda, Sarac Gulbahar, Cenk Hulya
Department of Dermatology, Turgut Ozal Medical Center, Inonu University Faculty Of Medicine, Malatya, Turkey.
Department of Dermatology, Malatya Training and Research Hospital, Malatya, Turkey.
Lasers Med Sci. 2019 Feb;34(1):93-98. doi: 10.1007/s10103-018-2606-6. Epub 2018 Aug 10.
Various lasers have been used for the treatment of erythematotelangiectatic rosacea (ETR), facial erythema (FE), and facial telangiectasias (FT). The assessment of the treatments of all of these conditions with a 577-nm pro-yellow laser has not been reported yet. The aim of this work was to assess the efficacy and safety of the 577-nm pro-yellow laser in ETR, FE, and FT. Forty patients suffering from ETR, FE, and FT (25 female and 15 male) were enrolled in this study. All of the patients were treated with 577-nm pro-yellow laser (QuadroStarPRO YELLOW® Asclepion Laser Technologies, Germany) at 4-week intervals, for one to four sessions. The assessment of the treatment was made based on the digital photographs and the percentage of fading of the erythema and telangiectasias in the lesions. Significant clinical improvement (80-100%) was observed in the first or second sessions of the treatment in FE and ETR patients and in second and fourth sessions of the treatment in FT patients. The treatment was very well tolerated. No side effect was observed except for a few patients who had mild to moderate erythema fading away in 12-24 h. This case series has shown that the pro-yellow laser is a very effective, safe, and well-tolerated treatment for ETR, FE, and FT.
各种激光已被用于治疗红斑毛细血管扩张型玫瑰痤疮（ETR）、面部红斑（FE）和面部毛细血管扩张（FT）。尚未有关于使用577纳米黄光激光治疗所有这些病症的评估报告。这项工作的目的是评估577纳米黄光激光治疗ETR、FE和FT的疗效和安全性。本研究纳入了40名患有ETR、FE和FT的患者（25名女性和15名男性）。所有患者均使用577纳米黄光激光（德国阿斯克勒庇俄斯激光技术公司的QuadroStarPRO YELLOW®），每隔4周治疗一次，共进行1至4次治疗。根据数码照片以及病变部位红斑和毛细血管扩张消退的百分比对治疗效果进行评估。FE和ETR患者在治疗的第一或第二次疗程中以及FT患者在治疗的第二和第四次疗程中观察到了显著的临床改善（80 - 100%）。该治疗耐受性良好。除了少数患者在12至24小时内出现轻度至中度红斑消退外，未观察到其他副作用。该病例系列表明，黄光激光是一种治疗ETR、FE和FT非常有效、安全且耐受性良好的方法。
